Leading Edge Urologypresented by

April 5–8, 2018Omni Hilton Head OceanfrontHilton Head, South Carolina

UROLOGYLEADING EDGE

50th

UROLOGIC CANCER SYMPOSIUM

annual

Duke Division of Urology

Duke Cancer Institute

DUKE UROLOGICASSEMBLY

Duke Urologic Assembly

DU

MC

370

7 •

Dur

ham

, NC

277

1039

1-83

22

LEA

DIN

G E

DG

EU

RO

LOG

Y

Firs

t Cla

ss M

ail

U.S

. Pos

tage

PAID

Dur

ham

, NC

Perm

it N

o. 6

0

50TH

AN

NU

AL

DU

KE

UR

OLO

GIC

ASS

ESM

BLY

& U

RO

LOG

IC C

AN

CER

SYM

PO

SIU

M

Ap

ril

5–8,

201

8

surg

ery.

du

ke.

edu

/DU

A20

18

CONFERENCE AGENDAApril 5–8, 2018

THURSDAY10:00 am – 5:30 pm Registration and Exhibits

12:15 pm Welcome

SESSION I 12:30 pm Partial Nephrectomy Techniques for Renal Preservation: Historical and Modern Approaches

1:00 pmImaging and Interpretation of Renal Neoplasms for Urologists

1:30 pmInherited Tumor Syndromes: A Review for the Urologist

2:00 pm Systemic Therapy for Renal Cell Carcinoma

2:30 pm Case Discussions

3:00 pm Break in the Exhibit Hall

SESSION II 3:15 pmProstate Cancer Research at Duke: Where We Have Been, Where We Are, And Where We Are Going

3:45 pmTranslating Trials to Practice – Updates in Prostate Radiotherapy

4:15 pm ADT – Current Options and Controversies

4:45 pm The Perineal Prostatectomy: Walking In the Land of the Dinosaurs

5:15 pmRobotic Training Outside the USA

5:45 pmCase Discussions

6:15 pmSession Adjournment

6:30 Welcome Reception

FRIDAY6:30 am Registration, Breakfast and Exhibits

SESSION III 7:00 am Managing and Preventing Complications From Major Urological Surgery

7:30 am Old and New – Radiation for Bladder and Upper Tract Cancers

8:00 amUpdates in Immunotherapy for Urothelial Carcinoma

8:30 am Updating Imaging for Renal Cystic Disease

9:00 am Diabetic Bladder Dysfunction

9:30 am Break in the Exhibit Hall

SESSION IV 9:45 am 2018 VICTOR A. POLITANO, MD LECTURESHIP presented by DeVere White: AUA Guide Lines for Urothelial Ca Consequences of Ignoring Them

10:15 am Coding And Reimbursement Update, Highlights of the AUA Course From 2018

10:45 am Hormonal Sensitive Prostate Cancer: What Do STAMPEDE and LATTITUDE Teach Us?

11:15 am Biomarkers in Prostate Cancer

11:45 am Biological Differences in African-American Prostate Cancer

12:15 pm 2018 VICTOR A. POLITANO, MD LUNCHEON (NON CME)

1:00 pm The Role of Rescue/Salvage Lymphadenectomy in Prostate Cancer

1:30 pm History of Duke Urology (Part 1) – From Alyea through Paulson

History of Duke Urology (Part2) – From Paulson to Preminger

2:00 pm Session Adjournment

SATURDAY6:30 am Breakfast and Exhibits

SESSION V 7:00 am Predictive Medicine for Men with Metastatic Prostate Cancer

7:30 am Muscle Invasive Urothelial Cancer

8:00 am Male Health and Infertility

8:30 am 10 Year Update on Male Slings for Post-Prostatectomy Incontinence

9:00 am The Evolution of Sacral Modulation for the Treatment of Voiding Dysfunction

9:30 am Prostate Cancer in the Era of Focal Therapy: Is Image Guided Therapy Effective?

10:00 am Break in the Exhibit Hall

SESSION VI

10:15 am IPP Infection Prevention

10:45 am A New Paradigm for Bladder Outlet Obstruction

11:15 am Minimally Invasive Approaches to BPH

11:45 am Evolution of Hypospadias Repair

12:15 pm Avoiding the “Black Swan” Event: Perioperative Management of Cardio-Ischemic / Embolic Risk

12:45 pm Case Discussions

1:15 pm Session Adjournment

SUNDAY6:30 am Breakfast and Exhibits

SESSION VII 7:00 am Surgical Stone Guidelines: Perspectives from the AUA Nephrolithiasis Guidelines Panel

7:30 am Dietary, Nutritional and Medical Management of Urolithiasis

8:00 am The Conundrum of Medical Expulsive Therapy

8:30 am Evaluation and Treatment of the Subfertile Male

9:00 am Adjuvant Medical Therapy Following Surgical Stone Management

9:30 am Case Discussions

10:00 am Conference Adjournment

*Opportunities for Q&A will be provided at the conclusion of each presentation.

COURSE OVERVIEW

Join your colleagues and fellow alumni to celebrate the 50th

Duke Urologic Assembly!

In celebration of this golden anniversary, we have assembled an outstanding roster of Duke alumni, faculty, and national leaders participating in a comprehensive scientific program that provides effective and efficient evidence- based information and resources to the healthcare provider and

team specializing in the diagnosis and treatment of conditions and diseases related to urology and urologic oncology.

Healthcare professionals attending this symposium will be engaged through interactive talks, video surgical presentations, interactive case presentations, and panel discussions on the latest evidence-based clinical approaches to managing a wide range of urologic conditions.

LEARNING OBJECTIVES• Apply effective and efficient

diagnosis and treatments in the sub-specialties of urology and urologic oncology

• Analyze new technologies and therapies to provide the utmost, least invasive care to patients

• Evaluate and outline management options for the various urologic conditions

• Choose appropriate patients for minimally-invasive surgical approaches

• Distinguish various surgical approaches and compare their effectiveness and safety profiles

• Identify the currently available biomarkers, the pros and cons of each, as well as where in the schema they are optimally utilized

• Develop collaboration between urologists, genitourinary oncologists, and radiation oncologists for patient care from diagnosis to management

TARGET AUDIENCE

This program is designed to meet the continuing educational needs

of urologists, oncologists, physician assistants, nurse practitioners, registered nurses, urology residents, and allied health professionals. David M. Albala, MD

Chief of Urology, Crouse Hospital, Medical Director and Co-Director of Research for Associated Medical Professionals Syracuse, NY

Lance Coetzee, MDRobotic Surgeon, Urology Hospital, PretoriaSenior Consultant Urologist Department of Urology University of PretoriaPretoria, South Africa

Philipp Dahm, MD, MHSc, FACSProfessor of Urology and Vice Chair of Veterans Affairs, University of Minnesota; Director for Surgery/Specialty Care Service Line Research Activities; Coordinating Editor, Cochrane Urology Group

Anurag K. Das, MD, FACSAssistant Professor of Surgery, Harvard Medical SchoolDirector, Center for Neuro-urology and ContinenceBeth Israel Deaconess Medical Center

Edmond T. Gonzales, MDDirector of SurgeryTexas Children’s HospitalHouston, TX

Sam D. Graham, Jr., MDUrologist, Augusta HealthChair at Emory University Medical Director, Thomas Johns Cancer HospitalBlue Ridge Urological, Fishersville, VA

Ronald P. Kaufman, Jr., MD, FACSAssociate Professor of SurgeryAlbany Medical College Department of Surgery, Division of UrologyAlbany, NY

Thomas E. Keane, MBBCh, FRCSI, FACSChief, Specialty Surgery Integrated Center for Comprehensive ExcellenceProfessor & Chairman of Urology Medical University of South Carolina, Charleston, SC

DYSURIA GUEST FACULTY SPEAKERS

DIVISION OF MEDICAL ONCOLOGY

Andrew J. Armstrong, MD, MSc, FACPAssociate Professor of Medicine, Surgery, Pharmacology & Cancer BiologyAssociate Director for Clinical Research in Genitourinary Oncology

Daniel J. George, MD Professor of Medicine Professor in Surgery

Steven R. Patierno, PhDDeputy Director, Duke Cancer InstituteProfessor of MedicineProfessor of Pharmacology and Cancer BiologyProfessor in Community and Family Medicine

DIVISIONS OF RADIATION & ONCOLOGY

Bridget F. Koontz, MDAssociate Professor of Radiation Oncology

Richard A. Leder, MDAssociate Professor of RadiologyClinical Associate in Surgery

DUKE UNIVERSITY FACULTY

DIVISION OF UROLOGY

Karen C. Baker, MDAssociate Professor of Surgery

Brant A. Inman, MD, MS, FRCSCCary N. Robertson Associate Professor of Surgery

Aaron C. Lentz, MDAssociate Professor of Surgery

Judd W. Moul, MDJames H. Semans, MD, Professor of Urologic Surgery, Surgery, and Anesthesoliogy

David F. Paulson, MDProfessor Emeritus of Surgery

J. Todd Purves, MD, PhDAssociate Professor of Surgery

Cary N. Robertson, MD, FACSAssociate Professor of Surgery

Philip J. Walther, MD, PhD, MBA, FACSProfessor of Surgery, Associate Prof. of Pathology

John S. Wiener, MDHead, Section of Pediatric UrologyProfessor of Surgery and Pediatrics

Sarah Yttri, RN, MSN, ANP-CNurse Practitioner

2018 LEADING EDGE UROLOGY MEDICAL DIRECTORSMichael N. Ferrandino, MDAssociate Professor of SurgeryDirector, Minimally Invasive Urologic SurgeryDuke Department of Surgery, Division of Urology

Michael N. Ferrandino, MDGlenn M. Preminger, MDJames F. Glenn, MD, Prof. of Urology Chief, Division of UrologyProfessor of SurgeryDuke Department of Surgery, Division of Urology

2018 VICTOR A. POLITANO, MD, LECTURESHIP SPEAKERRalph W. de Vere White, MDSenior Advisor Emeritus and Emeritus Distinguished Professor of UrologyUC Davis Comprehensive Cancer CenterSacramento, CA

CANCELLATION POLICY

A $50 cancellation fee will apply for cancellations received in writing more than 14 days prior to the start of the course. There will be no refunds if canceling within 14 days of the start of the course.

SPECIAL ASSISTANCE

Duke Urology is committed to making its activities accessible to all individuals.

CONTACT / QUESTIONS

For questions, special assistance, or sponsorship, please contact 919-668-3532 or submit your request in writing to dukeurocme@duke.edu.

ACCOMMODATIONS

Omni Hilton Head Oceanfront Resort(843) 842-8000, reference Duke Urologic Assembly

A limited block of rooms has been reserved at a special rate of $229 per night plus tax. At more than 530 square feet with mini kitchens and private balconies, the Studio Suites are the largest, newest, and most comfortable resort accommodations on the island.

Please note these dates are during a high demand time. The cut-off date for accepting reservations into this discounted room block is Monday, February 26, 2018 or until the room block is full. Afterward, reservations will be subject to availability and prevailing room rates.

ACCREDITATION

In support of improving patient care, the Duke University Health System Department of Clinical Education and Professional Development is accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the health care team.

Physician: Duke University Health System Department of Clinical Education and Professional Development designates this live activity for a maximum of 20.5 AMA PRA Category

1 Credit(s)TM. Physicians should claim only credit commensurate with the extent of their participation in the activity.

Nurse ANCC: Duke University Health System Department of Clinical Education and Professional Development designates this activity for up to 20.5 ANCC credit hours for nurses. Nurses should claim only credit commensurate with the extent of their participation in this activity.

REGISTER ONLINE AT surgery.duke.edu/DUA2018

Physician $600 $650

PA, NP, RN $375 $425